These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical and investigative approaches in mitochondrial diseases. A review of 15 cases]. Arpa J; Campos Y; Cruz Martínez A; Gutiérrez Molina M; Arenas J; Alonso M; Plaza I; Morales C; Palomo F; Barreiro P Neurologia; 1994 Oct; 9(8):324-36. PubMed ID: 7803049 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation. Fosslien E Ann Clin Lab Sci; 2001 Jan; 31(1):25-67. PubMed ID: 11314862 [TBL] [Abstract][Full Text] [Related]
5. 163rd ENMC International Workshop: nucleoid and nucleotide biology in syndromes of mitochondrial DNA depletion myopathy 12-14 December 2008, Naarden, The Netherlands. Poulton J; Holt IJ Neuromuscul Disord; 2009 Jun; 19(6):439-43. PubMed ID: 19464176 [No Abstract] [Full Text] [Related]
17. The genetics and pathology of oxidative phosphorylation. Smeitink J; van den Heuvel L; DiMauro S Nat Rev Genet; 2001 May; 2(5):342-52. PubMed ID: 11331900 [TBL] [Abstract][Full Text] [Related]
18. MRI in myopathy. Lovitt S; Marden FA; Gundogdu B; Ostrowski ML Neurol Clin; 2004 Aug; 22(3):509-38, v. PubMed ID: 15207874 [TBL] [Abstract][Full Text] [Related]
19. Altered skeletal muscle (mitochondrial) properties in patients with mitochondrial DNA single deletion myopathy. Gehrig SM; Mihaylova V; Frese S; Mueller SM; Ligon-Auer M; Spengler CM; Petersen JA; Lundby C; Jung HH Orphanet J Rare Dis; 2016 Jul; 11(1):105. PubMed ID: 27473873 [TBL] [Abstract][Full Text] [Related]
20. Maternal inheritance and the evaluation of oxidative phosphorylation diseases. Shoffner JM Lancet; 1996 Nov; 348(9037):1283-8. PubMed ID: 8909383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]